Effects of Body Awareness Therapy on Posture, Trunk Movement, Scoliosis & Body Awareness in Adolescents With Scoliosis
Launched by GÖZDE YAGCI (GÜR) · Feb 28, 2025
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a therapy called Basic Body Awareness Therapy (BBAT) on adolescents with a condition known as adolescent idiopathic scoliosis (AIS), which is a curvature of the spine that usually appears during growth. The trial aims to see how BBAT, when combined with another exercise approach called the Scientific Exercise Approach to Scoliosis (SEAS), can improve things like posture, movement, and overall quality of life for young people aged 10 to 17 who have scoliosis that is 15 degrees or more.
To be eligible for this trial, participants need to have been diagnosed with AIS and not have received any previous treatment for it. They should not have any other spinal deformities, wear a brace, or have certain medical conditions. During the study, participants will attend weekly sessions at the clinic and will also do specific exercises at home. This research hopes to find out if adding BBAT to the existing rehabilitation exercises can lead to better outcomes for adolescents with scoliosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with adolescent idiopathic scoliosis
- • Being between the ages of 10 and 17
- • Having scoliosis of 15° or greater
- • Not having received previous treatment for scoliosis and not receiving any other treatment during this study
- • Risser stage 0-4
- • Willing to participate in the study
- Exclusion Criteria:
- • Having any spinal/bone deformity in addition to scoliosis (such as hyperkyphosis, pectus, etc.)
- • Wearing a brace
- • Having congenital scoliosis
- • Having any rheumatological, neuromuscular, neurological, cardiovascular, or pulmonary pathology
- • Having a regular history or habit of physical activity
- • Having undergone scoliosis surgery
About Gözde Yagci (Gür)
Gözde Yagci (Gür) is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative clinical studies. With a commitment to ethical practices and regulatory compliance, Yagci (Gür) collaborates with leading healthcare professionals and institutions to explore cutting-edge therapies and treatment modalities. The organization emphasizes patient safety and data integrity, aiming to contribute valuable insights to the scientific community and enhance the quality of care across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Ankara, , Turkey
Patients applied
Trial Officials
Gözde Yağcı, Prof. Dr.
Study Director
Hacettepe University
Sena Yaylacı, MSc, PT
Principal Investigator
Hacettepe University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported